Literature DB >> 22478963

Evidence to support development of pharmacy services: how much or how little do we need?

Scot H Simpson1.   

Abstract

Year:  2010        PMID： 22478963      PMCID： PMC2858513          DOI： 10.4212/cjhp.v63i2.886

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  9 in total

Review 1.  Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials.

Authors:  Gordon C S Smith; Jill P Pell
Journal:  BMJ       Date:  2003-12-20

2.  Overview of the Veterans Health Administration (VHA) Quality Enhancement Research Initiative (QUERI).

Authors:  Lynn McQueen; Brian S Mittman; John G Demakis
Journal:  J Am Med Inform Assoc       Date:  2004-06-07       Impact factor: 4.497

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  [Not Available].

Authors:  Jean-François Bussières; Antoine Robelet; Roxane Therrien; Karine Touzin
Journal:  Can J Hosp Pharm       Date:  2010-03

5.  Care providers' satisfaction with restructured clinical pharmacy services in a tertiary care teaching hospital.

Authors:  Tania M Mysak; Christine Rodrigue; Jane Xu
Journal:  Can J Hosp Pharm       Date:  2010-03

Review 6.  A clinician's guide to cost-effectiveness analysis.

Authors:  A S Detsky; I G Naglie
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

7.  Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research.

Authors:  C M Kozma; C E Reeder; R M Schulz
Journal:  Clin Ther       Date:  1993 Nov-Dec       Impact factor: 3.393

8.  Effect of ramipril on the incidence of diabetes.

Authors:  Jackie Bosch; Salim Yusuf; Hertzel C Gerstein; Janice Pogue; Patrick Sheridan; Gilles Dagenais; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Jeffrey Probstfield; George Fodor; Rury R Holman
Journal:  N Engl J Med       Date:  2006-09-15       Impact factor: 91.245

9.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.